At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 8 enrolled
Drug / intervention
IRE Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trial Of IRE in Cholangiocarcinoma (TOnIC): Phase II
In Brief
A Phase 2 clinical trial evaluating IRE Device for Cholangiocarcinoma. Completed, enrolled 8 participants across 7 sites.
Detailed Summary
The purpose of this study is to test any good and bad side effects of surgery using IRE to treat cancer of the bile duct.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCholangiocarcinoma
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedDec 2018
Primary CompletionAug 2021
TodayJul 2026
First PostedDec 7, 2018
Enrollment StartDec 5, 2018
Primary CompletionAug 16, 2021
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 7.6 years ago
Interventions
IRE Devicedevice
For use in ablating soft tissue